Abstract
No public abstract is available from the verified source records.
Matheus Loiola Magalhães Alves, Antônio Olímpio da Silva Moura Costa, Julia do Vale Moura Costa, Gustavo Azevedo Garrido, João Victor Pereira Gonzalez, Julia Sader Neves Ferreira, Bernardo de Andrada Pereira
Abstract
Authors
Institutions
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Unresolved referenced work
2025
Once-weekly semaglutide in adults with overweight or obesity
10.1056/nejmoa2032183 · 2021
Tirzepatide once weekly for the treatment of obesity
10.1056/nejmoa2206038 · 2022
Semaglutide and cardiovascular outcomes in obesity without diabetes
10.1056/nejmoa2307563 · 2023
Receptors and effects of gut hormones in three osteoblastic cell lines
10.1186/1472-6793-11-12 · 2011
A systematic review of the effect of semaglutide on lean mass: insights from clinical trials
10.1080/14656566.2024.2343092 · 2024
The impact of GLP-1 agonists on bone metabolism: a systematic review
10.3390/medicina58020224 · 2022
Trends in resource utilization and rate of cervical disc arthroplasty and anterior cervical discectomy and fusion throughout the United States from 2006 to 2013
10.1016/j.spinee.2017.10.072 · 2018
Postoperative complications of anterior cervical discectomy and fusion: a comprehensive systematic review and meta-analysis
2025
Glucagon-like peptide-1 receptor agonist use does not impact spine surgery outcomes: a systematic review and meta-analysis
Provenance
crossref
Confidence 100%
ror
Confidence 99%
ror
Confidence 99%
ror
Confidence 99%
openalex
Confidence 95%
datacite
Confidence 0%
10.1177/21925682251415347 · 2026
Do GLP-1 agonists affect perioperative risk in spine surgery? A systematic review and meta-analysis
2026
Efficacy and safety of glucagon-like peptide-1 receptor agonists for spinal fusion outcomes: a comprehensive meta-analysis
2025
Impact of perioperative GLP-1 agonist use on pseudarthrosis rates following single-level anterior cervical discectomy and fusion: a propensity-matched cohort study
10.21037/jss-25-142 · 2026
The effect of GLP-1 receptor agonists on reoperation following anterior cervical discectomy and fusion
10.1016/j.wneu.2025.124751 · 2026
Semaglutide use is associated with higher rates of pseudarthrosis and dysphagia in patients undergoing posterior cervical fusion
10.1016/j.spinee.2025.03.023 · 2025
Unresolved referenced work
2024
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
2021
Meta-analysis of observational studies in epidemiology: a proposal for reporting
10.1001/jama.283.15.2008 · 2000
Rayyan-a web and mobile app for systematic reviews
10.1186/s13643-016-0384-4 · 2016
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
2016
Unresolved referenced work
2026
The Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird method
10.1186/1471-2288-14-25 · 2014
Measuring inconsistency in meta-analyses
10.1136/bmj.327.7414.557 · 2003
GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables
10.1016/j.jclinepi.2010.04.026 · 2011
Glucagon-like peptide-1 receptor agonist use and perioperative outcomes after anterior cervical discectomy and fusion: a propensity-matched cohort study
10.1016/j.spinee.2025.12.019 · 2026
Perioperative GLP-1 receptor agonist use is associated with reduced revisions and complications following ACDF: a propensity-matched analysis
2026
Glucagon-like peptide-1 receptor agonist use and clinical outcomes after posterior cervical spinal fusion for degenerative pathologies: a large cohort retrospective analysis
2026
Fusion outcomes of GLP-1 agonist therapy in multilevel cervical spinal fusion: a propensity-matched analysis
10.1097/bsd.0000000000001775 · 2025
Fusion outcomes of GLP-1 agonist therapy in multilevel cervical spinal fusion: a propensity-matched analysis
10.1097/bsd.0000000000001775 · doi-reference
Glucagon-like peptide-1 receptor agonist use and perioperative outcomes after anterior cervical discectomy and fusion: a propensity-matched cohort study
10.1016/j.spinee.2025.12.019 · doi-reference
GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables
10.1016/j.jclinepi.2010.04.026 · doi-reference
Measuring inconsistency in meta-analyses
10.1136/bmj.327.7414.557 · doi-reference
The Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird method
10.1186/1471-2288-14-25 · doi-reference
Rayyan-a web and mobile app for systematic reviews
10.1186/s13643-016-0384-4 · doi-reference
Meta-analysis of observational studies in epidemiology: a proposal for reporting
10.1001/jama.283.15.2008 · doi-reference
Semaglutide use is associated with higher rates of pseudarthrosis and dysphagia in patients undergoing posterior cervical fusion
10.1016/j.spinee.2025.03.023 · doi-reference
The effect of GLP-1 receptor agonists on reoperation following anterior cervical discectomy and fusion
10.1016/j.wneu.2025.124751 · doi-reference
Impact of perioperative GLP-1 agonist use on pseudarthrosis rates following single-level anterior cervical discectomy and fusion: a propensity-matched cohort study
10.21037/jss-25-142 · doi-reference
Glucagon-like peptide-1 receptor agonist use does not impact spine surgery outcomes: a systematic review and meta-analysis
10.1177/21925682251415347 · doi-reference
Trends in resource utilization and rate of cervical disc arthroplasty and anterior cervical discectomy and fusion throughout the United States from 2006 to 2013
10.1016/j.spinee.2017.10.072 · doi-reference
The impact of GLP-1 agonists on bone metabolism: a systematic review
10.3390/medicina58020224 · doi-reference
A systematic review of the effect of semaglutide on lean mass: insights from clinical trials
10.1080/14656566.2024.2343092 · doi-reference
Receptors and effects of gut hormones in three osteoblastic cell lines
10.1186/1472-6793-11-12 · doi-reference
Semaglutide and cardiovascular outcomes in obesity without diabetes
10.1056/nejmoa2307563 · doi-reference
Tirzepatide once weekly for the treatment of obesity
10.1056/nejmoa2206038 · doi-reference
Once-weekly semaglutide in adults with overweight or obesity
10.1056/nejmoa2032183 · doi-reference